Inventors list |
Assignees list |
Classification tree browser |
Top 100 Inventors |
Top 100 Assignees |
Smeal
Brad Smeal, Bethel Park, PA US
| Patent application number | Description | Published |
|---|---|---|
| 20090168652 | SYSTEM AND METHOD FOR AUDITING ROUTE PARAMETERS IN A NETWORK - A system includes a collector module configured to collect route parameters from a selected node of a plurality of nodes in the network, wherein the route parameters from the selected node are indicative of a first route to a destination address and a second route to the destination address; and a route processor configured to determine a first intermediate node along the first route communicatively coupled to the destination address and a second intermediate node along the first route communicatively coupled to the destination address, based at least in part on the collected route parameters. A method includes collecting route parameters from a first intermediate node and a second intermediate node that can be configured to communicatively couple a source node to the destination node, determining at least a first route through the first intermediate node and a second route through the second intermediate node, and determining which route among the first route and the second route is optimal according to one or more criteria | 07-02-2009 |
Glen W. Smeal, San Marcos, TX US
| Patent application number | Description | Published |
|---|---|---|
| 20080206076 | Vertical Pump Arrangement - In one aspect, a pump having a pump module and a motor module includes a support member that substantially supports a weight of the motor module and uncouples the pump module from the weight of the motor module. | 08-28-2008 |
Tod R. Smeal, San Diego, CA US
| Patent application number | Description | Published |
|---|---|---|
| 20090215063 | Phosphospecific PAK antibodies and diagnostic kits - The present invention relates to the use of phosphorylated p21-activated protein kinases (PAK), especially PAK4, as biomarkers of tumorogenesis. The present invention contemplates the use of phosphospecific antibodies for detecting phosphorylated PAK from mammalian biopsies, as well as screening assays for identifying compounds that modulate PAK activity. Also contemplated is a method for determining a subset of a given population that is amenable to treatment with a compound that modulates PAK activity. | 08-27-2009 |
Tod R. Smeal, San Francisco, CA US
| Patent application number | Description | Published |
|---|---|---|
| 20090130695 | GEF-H1b: biomarkers, complexes, assays and therapeutic uses thereof - The present invention relates to diagnosing abnormal cell proliferation in biological samples and screening for drugs which inhibit, reduce or abolish cell growth, especially tumorigenic cell growth, by detecting a phosphovariant isoform of a guanine nucleotide exchange factor biomarker, such as the novel GEF-H1S. | 05-21-2009 |
| 20110159532 | GEF-H1b: BIOMARKERS, COMPLEXES, ASSAYS AND THERAPEUTIC USES THEREOF - The present invention relates to diagnosing abnormal cell proliferation in biological samples and screening for drugs which inhibit, reduce or abolish cell growth, especially tumorigenic cell growth, by detecting a phosphovariant isoform of a guanine nucleotide exchange factor biomarker, such as the novel GEF-H1S. | 06-30-2011 |